LOW-VOLUME · SEX-BALANCED
fluocinonide Side Effects
fluocinonide (also sold as Lidex, Vanos) is a LOW-VOLUME FAERS extract #388 of 524 by FAERS report count. Still opens on SEX-BALANCED: 60% of sex-coded reports are female (3,063 F / 2,027 M).
Data updated 2026-05-15
- 5,460
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
fluocinonide reporting skew - 60% of sex-coded reports are female (3,063 F / 2,027 M). Volume band LOW-VOLUME #388 of 524 by FAERS report count; caseload WATCHLIST.
Thinner FAERS extract for fluocinonide (Lidex) (5,460 reports #388 of 524 by FAERS report count). 60% of sex-coded reports are female (3,063 F / 2,027 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
PSORIASIS leads 544 of 5,460 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (1,196 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death appears on 255 reports (4.7% - MARKED). Reactions below co-occur in those rows only.
| Reaction | Reports |
|---|---|
| DEATH | 127 |
| CHRONIC KIDNEY DISEASE | 25 |
| ACUTE KIDNEY INJURY | 21 |
| RENAL FAILURE | 19 |
| END STAGE RENAL DISEASE | 16 |
| HYPOTENSION | 15 |
| MYOCARDIAL INFARCTION | 15 |
| SEPSIS | 15 |
| DYSPNOEA | 14 |
| ASTHENIA | 12 |
| CARDIAC ARREST | 11 |
| PNEUMONIA | 11 |
| RESPIRATORY FAILURE | 11 |
| FATIGUE | 10 |
| DISEASE PROGRESSION | 9 |
| NEPHROGENIC ANAEMIA | 9 |
| PAIN | 9 |
| DIARRHOEA | 8 |
| NAUSEA | 8 |
Reactions in Hospitalization Reports
Hospitalization mid-share (1,006, 18.4%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| PNEUMONIA | 91 |
| DYSPNOEA | 89 |
| PAIN | 87 |
| FATIGUE | 74 |
| NAUSEA | 70 |
| DIARRHOEA | 69 |
| RASH | 65 |
| VOMITING | 59 |
| PYREXIA | 56 |
| DIZZINESS | 55 |
| FALL | 55 |
| ANXIETY | 52 |
| ASTHENIA | 51 |
| ACUTE KIDNEY INJURY | 50 |
| HEADACHE | 49 |
| HYPERTENSION | 46 |
| MALAISE | 46 |
| RENAL FAILURE | 45 |
| URINARY TRACT INFECTION | 44 |
| COUGH | 43 |
How to read fluocinonide FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-MID)
FAERS holds 5,460 voluntary reports linked to fluocinonide (Lidex, Vanos), 2004-2025. Death is listed on 255 (4.7%). Hospitalization appears on 1,006 (18.4%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with fluocinonide
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-MID stamps.
ABS(total_reports) peer at 5,503 FAERS cases (Δ 43 heavier vs fluocinonide); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 5,567 FAERS cases (Δ 107 heavier vs fluocinonide); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 5,342 FAERS cases (Δ 118 lighter vs fluocinonide); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 5,230 FAERS cases (Δ 230 lighter vs fluocinonide); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-MARKED · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 57.4 pp vs fluocinonide's DEATH-MARKED): CASELOAD · HOSP-MID.
fluocinonide stamps WATCHLIST · SEX-BALANCED; class peers and methodology beat restating the same FAERS caveats on every effects URL.